Hepatorenal Syndrome
Hepatorenal syndrome (HRS) is a functional form of acute kidney failure that occurs in advanced liver disease. It develops in the absence of intrinsic kidney pathology and is characterised by severe circulatory dysfunction rather than structural renal damage. HRS is a late and life-threatening complication of portal hypertension and cirrhosis. Its onset often signals significant hepatic decompensation. Understanding the underlying haemodynamic mechanisms explains why kidney function deteriorates despite initially normal renal structure.
What You Need to Know
Hepatorenal syndrome is a form of functional kidney failure that occurs in advanced liver disease, most commonly in the setting of cirrhosis with portal hypertension. It develops because profound vasodilation within the splanchnic circulation causes a large proportion of blood volume to pool in the abdominal vasculature. Although total body fluid is often increased, effective arterial blood volume falls, meaning less blood is available to perfuse vital organs. The kidneys interpret this state as true hypovolaemia and activate compensatory mechanisms in an attempt to maintain glomerular filtration.
Persistent neurohormonal activation is central to disease progression. The renin–angiotensin–aldosterone system, sympathetic nervous system, and antidiuretic hormone remain chronically activated, leading to intense renal vasoconstriction and ongoing sodium and water retention. While these responses are initially adaptive, over time they critically reduce renal blood flow. Glomerular filtration rate declines despite structurally normal kidneys, distinguishing hepatorenal syndrome from intrinsic renal disease.
Several interconnected processes explain why renal function deteriorates despite overall fluid overload:
severe splanchnic vasodilation reducing effective arterial blood volume
sustained neurohormonal activation driving renal vasoconstriction
progressive reduction in renal perfusion without primary kidney pathology
Alcohol plays an important role by accelerating the underlying haemodynamic disturbance. Chronic alcohol use worsens liver injury and portal hypertension, perpetuating splanchnic vasodilation and circulatory dysfunction. Alcohol-related complications, particularly spontaneous bacterial peritonitis and gastrointestinal bleeding, frequently act as precipitating events that tip renal perfusion below a critical threshold. Sustained abstinence reduces progression of liver disease and is a key factor in lowering the risk and severity of hepatorenal syndrome.
Beyond the Basics
Splanchnic vasodilation and arterial underfilling
The initiating event in hepatorenal syndrome is widespread vasodilation within the splanchnic circulation, the blood supply to the gastrointestinal organs. Increased production of nitric oxide, a potent vasodilator, reduces vascular tone and allows large volumes of blood to pool within the abdominal vessels. This redistribution creates a state of arterial underfilling, where the effective circulating volume supplying vital organs is reduced despite normal or increased total blood volume.
Reduced arterial pressure is sensed by baroreceptors and interpreted as hypovolaemia. In response, compensatory mechanisms are activated to preserve perfusion of the heart and brain. Renal blood flow is sacrificed as part of this prioritisation, setting the stage for progressive renal hypoperfusion even though overall fluid status may suggest overload rather than depletion.
Renal vasoconstriction and reduced filtration
As compensatory responses intensify, renal vasoconstriction becomes the dominant feature of hepatorenal syndrome. Angiotensin II and sympathetic nervous system activation constrict both afferent and efferent arterioles within the kidney, reducing renal plasma flow. This vasoconstriction lowers hydrostatic pressure within the glomerulus and limits filtration, leading to a progressive fall in glomerular filtration rate.
Importantly, renal parenchyma remains structurally intact in early disease, which distinguishes hepatorenal syndrome from intrinsic renal pathology such as acute tubular injury. The decline in kidney function is therefore functional rather than structural at this stage. With persistent hypoperfusion, however, adaptive mechanisms fail and renal function continues to deteriorate.
Sodium and water retention
Neurohormonal activation promotes aggressive sodium and water retention as the body attempts to restore effective circulating volume. Aldosterone increases sodium reabsorption in the distal nephron, while antidiuretic hormone increases free water reabsorption in the collecting ducts. These processes expand total body fluid but do not correct arterial underfilling.
The consequence is worsening ascites, peripheral oedema, and dilutional hyponatraemia, where serum sodium concentration falls due to excess water retention. Despite increasing fluid accumulation, renal perfusion remains inadequate, creating a cycle in which fluid overload and renal dysfunction progress together.
Role of systemic inflammation
Systemic inflammation plays an important role in precipitating hepatorenal syndrome, particularly in advanced cirrhosis. Infections such as spontaneous bacterial peritonitis trigger cytokine release that further amplifies splanchnic vasodilation and impairs vascular responsiveness. Inflammatory mediators can also depress cardiac output, limiting the ability to compensate for reduced vascular tone.
These changes explain why hepatorenal syndrome may develop abruptly in patients who were previously stable. The combined effects of inflammation, vasodilation, and reduced effective circulating volume can rapidly tip renal perfusion below a critical threshold.
Alcohol and progression to irreversible renal failure
Alcohol exacerbates each stage of this process by sustaining hepatic injury and promoting chronic inflammation. Continued alcohol intake worsens portal hypertension, increases the likelihood of infection and gastrointestinal bleeding, and amplifies circulatory instability. These factors increase both the frequency and severity of hepatorenal syndrome episodes.
With prolonged or repeated episodes of renal hypoperfusion, functional kidney failure may progress to structural injury. Once intrinsic renal damage develops, reversibility is reduced and prognosis worsens significantly. Sustained alcohol abstinence is therefore central to limiting progression and preserving the potential for renal recovery.
Clinical Connections
Hepatorenal syndrome typically presents with a progressive rise in serum creatinine, reduced urine output, and very little proteinuria or haematuria, reflecting functional renal failure rather than intrinsic kidney damage. Patients usually have advanced cirrhosis with tense ascites and dilutional hyponatraemia, which signal severe circulatory dysfunction. HRS often develops after a clear precipitating event such as infection, gastrointestinal bleeding, or excessive diuresis, when renal perfusion falls below a critical threshold. Without intervention, renal function can deteriorate rapidly, and mortality rates are high.
Clinical assessment centres on recognising this pattern early and distinguishing HRS from other causes of acute kidney injury. Diagnosis is based on characteristic renal impairment in the setting of advanced liver disease, lack of response to volume expansion, and exclusion of structural kidney disease or shock. Even small rises in creatinine are clinically significant in cirrhosis, as baseline creatinine is often low due to reduced muscle mass, meaning deterioration may be underestimated if changes are not interpreted carefully.
Key clinical features that should raise concern for evolving hepatorenal syndrome include:
rising creatinine or falling urine output despite adequate fluid resuscitation
low urinary sodium with minimal proteinuria or haematuria
associated features of advanced cirrhosis such as worsening ascites, hyponatraemia, or hypotension
Management relies on prompt identification, treatment of precipitating factors, and early escalation of care. Infections must be treated aggressively, gastrointestinal bleeding controlled, and potentially nephrotoxic medications avoided. Therapies aimed at improving effective arterial blood volume and renal perfusion are time sensitive, and delayed recognition is associated with poor response and worse outcomes. Preventing triggers and monitoring renal function closely in people with decompensated cirrhosis can significantly influence survival and the potential for renal recovery.
Concept Check
Why is hepatorenal syndrome considered a functional kidney failure?
How does splanchnic vasodilation reduce renal perfusion?
Why does sodium retention worsen ascites in HRS?
How can spontaneous bacterial peritonitis precipitate HRS?
Why does ongoing alcohol intake worsen prognosis?